ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

TBRG TruBridge Inc

13.55
-0.02 (-0.15%)
08 Nov 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
TruBridge Inc NASDAQ:TBRG NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.02 -0.15% 13.55 10.00 21.61 13.79 13.18 13.79 87,898 21:30:00

Form 8-K - Current report

08/08/2024 9:33pm

Edgar (US Regulatory)


false 0001169445 0001169445 2024-08-08 2024-08-08 0001169445 cpsi:CommonStockParValue0001PerShareCustomMember 2024-08-08 2024-08-08 0001169445 cpsi:CommonStockPurchaseRightsCustomMember 2024-08-08 2024-08-08
 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
 

 
FORM 8-K
 
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
 
Date of report (Date of earliest event reported): August 8, 2024
 
TRUBRIDGE, INC.
(Exact Name of Registrant as Specified in Charter)
 
Delaware
000-49796
74-3032373
(State or Other Jurisdiction
of Incorporation)
(Commission File
Number)
(IRS Employer
Identification No.)
     
54 St. Emanuel Street,
Mobile, Alabama
(Address of Principal Executive Offices)
 
36602
(Zip Code)
     
(251) 639-8100
(Registrant’s telephone number, including area code)
 
N/A
(Former Name or Former Address, if Changed Since Last Report)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
         Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
         Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
         Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
         Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each Class
 
Trading Symbol(s)
 
Name of each exchange on which registered
Common stock, par value $0.001 per share
 
TBRG
 
The NASDAQ Stock Market LLC
Common Stock Purchase Rights
 
N/A
 
The NASDAQ Stock Market LLC
 
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company          
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.                                 
    ☐
 
 

 
 
Item 2.02.         Results of Operations and Financial Condition.
 
On August 8, 2024, TruBridge issued a press release announcing financial information for its fiscal second quarter ended June 30, 2024. The press release is attached as Exhibit 99.1 to this Form 8-K and is furnished to, but not filed with, the Commission.

Item 9.01.          Financial Statements and Exhibits.
 
(d)         Exhibits.
 
ExhibitNumber
 
Exhibit
     
99.1
 
     
104
 
Cover Page Interactive Data File (embedded within the Inline XBRL document)
 
 

 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
TRUBRIDGE, INC.
By:
/s/ Vinay Bassi
Vinay Bassi
Chief Financial Officer and Treasurer
 
 
Dated: August 8, 2024
 

Exhibit 99.1

 tb01.jpg

 

 

TRUBRIDGE ANNOUNCES SECOND QUARTER 2024 RESULTS

 

MOBILE, ALA. (August 8, 2024) – TruBridge, Inc. (NASDAQ: TBRG), a healthcare solutions company, today announced financial results for the second quarter ended June 30, 2024.

 

Second Quarter 2024 Highlights

 

All comparisons are to the quarter ended June 30, 2023, unless otherwise noted

 

Total bookings of $23.3 million compared to $21.0 million

 

Total revenue of $84.7 million compared to $84.6 million

 

Revenue Cycle Management (RCM) revenue of $54.1 million compared to $47.8 million

 

o

RCM revenue represented 63.9% of TruBridge’s total revenue

 

GAAP (loss) earnings per diluted share of $(0.34) compared to $(0.20)

 

Non-GAAP earnings per diluted share of $0.16 compared to $0.40

 

Adjusted EBITDA of $12.6 million compared to $11.2 million

 

 

Chris Fowler, chief executive officer of TruBridge, Inc., stated, “We are pleased with our second quarter performance, both operationally and financially. The team continued to build on our bookings momentum and cross-selling efforts, while we further enhanced our financial operations. Our solid revenue performance and adjusted EBITDA margin expansion in the quarter was punctuated by a significant improvement in cash flow from operations.

 

“Given the health of our pipeline and clear line of sight for the remainder of the year, we are reiterating guidance and are enthusiastic about our future outlook,” concluded Fowler.

 

Financial Guidance

 

For the third quarter of 2024, TruBridge expects to generate:

 

Total revenue between $82 million and $85 million

 

Adjusted EBITDA between $11.5 million and $13.5 million

 

For the full year 2024, TruBridge reiterates prior outlook of:

 

Total revenue between $330 million and $340 million

 

Adjusted EBITDA between $45 million and $50 million

 

-MORE-


 

Conference Call

TruBridge will hold a conference call and live webcast to discuss second quarter 2024 results on Thursday, August 8, 2024, at 3:30 p.m. Central time/4:30 p.m. Eastern time. To access this interactive teleconference, dial (800) 715-9871 and request connection to the TruBridge earnings conference call. A 30-day online replay will be available approximately one hour following the conclusion of the live webcast. To listen to the live webcast or access the replay, visit the Company’s investor relations website, investors.trubridge.com.

 

About TruBridge

We are a trusted partner to more than 1,500 healthcare organizations with a broad range of technology-first solutions that address the unique needs and challenges of diverse communities, promoting equitable access to quality care and fostering positive outcomes. TruBridge has over four decades of experience in connecting providers, patients and communities with innovative data-driven solutions that create real value by supporting both the financial and clinical side of healthcare delivery. Our industry leading HFMA Peer Reviewed® suite of revenue cycle management (RCM) offerings combine unparalleled visibility and transparency to enhance productivity and support the financial health of healthcare organizations across all care settings. We support efficient patient care with electronic health record (EHR) product offerings that successfully integrate data between care settings. Above all, we believe in the power of community and encourage collaboration, connection, and empowerment with our customers. We clear the way for care. For more information, please visit www.trubridge.com.

 

Investor Relations Contact

Asher Dewhurst, ICR Westwicke

TBRGIR@westwicke.com

 

Media Contact

Tracey Schroeder

Chief Marketing Officer

Tracey.schroeder@trubridge.com

(251) 639-8100

 

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements can be identified generally by the use of forward-looking terminology and words such as expects, anticipates, estimates, believes, predicts, intends, plans, potential, may, continue, should, will and words of comparable meaning. Without limiting the generality of the preceding statement, all statements in this press release relating to the Companys future financial and operational results are forward-looking statements. We caution investors that any such forward-looking statements are only predictions and are not guarantees of future performance. Certain risks, uncertainties and other factors may cause actual results to differ materially from those projected in the forward-looking statements. Such factors may include: saturation of our target market and hospital consolidations; unfavorable economic or market conditions that may cause a decline in spending for information technology and services; significant legislative and regulatory uncertainty in the healthcare industry; exposure to liability for failure to comply with regulatory requirements; pandemics and other public health crises and related economic disruptions; transition to a subscription-based recurring revenue model and modernization of our technology; competition with companies that have greater financial, technical and marketing resources than we have; potential future acquisitions that may be expensive, time consuming, and subject to other inherent risks; our ability to attract and retain qualified client service and support personnel; disruption from periodic restructuring of our sales force; potential delay in the development of markets for our RCM service offering; potential inability to properly manage growth in new markets we may enter; potential disruption of our business due to our ongoing implementation of a new enterprise resource planning software solution; exposure to numerous and often conflicting laws, regulations, policies, standards or other requirements through our international business activities; potential litigation against us; our reliance on an international workforce which exposes us to various business disruptions; our utilization of artificial intelligence, which could expose us to liability or adversely affect our business if we cannot compete effectively with others using artificial intelligence; potential failure to develop new products or enhance current products that keep pace with market demands; failure of our products to function properly resulting in claims for medical and other losses; breaches of security and viruses in our systems resulting in customer claims against us and harm to our reputation; failure to maintain customer satisfaction through new product releases free of undetected errors or problems; failure to convince customers to migrate to current or future releases of our products; failure to maintain our margins and service rates; increase in the percentage of total revenues represented by service revenues, which have lower gross margins; exposure to liability in the event we provide inaccurate claims data to payors; exposure to liability claims arising out of the licensing of our software and provision of services; dependence on licenses of rights, products and services from third parties; misappropriation of our intellectual property rights and potential intellectual property claims and litigation against us; interruptions in our power supply and/or telecommunications capabilities, including those caused by natural disaster; potential inability to secure additional financing on favorable terms to meet our future capital needs; our substantial indebtedness, and our ability to incur additional indebtedness in the future; pressures on cash flow to service our outstanding debt; restrictive terms of our credit agreement on our current and future operations; changes in and interpretations of financial accounting matters that govern the measurement of our performance; significant charges to earnings if our goodwill or intangible assets become impaired; fluctuations in quarterly financial performance due to, among other factors, timing of customer installations; volatility in our stock price; failure to maintain effective internal control over financial reporting; inherent limitations in our internal control over financial reporting; vulnerability to significant damage from natural disasters; market risks related to interest rate changes; potential material adverse effects due to macroeconomic conditions, including bank failures or changes in related regulation; and other risk factors described from time to time in our public releases and reports filed with the Securities and Exchange Commission, including, but not limited to, our most recent Annual Report on Form 10-K and our Quarterly Report on Form 10-Q for the quarter ended June 30, 2024. We also caution investors that the forward-looking information described herein represents our outlook only as of this date, and we undertake no obligation to update or revise any forward-looking statements to reflect events or developments after the date of this press release.

 

-MORE-

TruBridge Announces Second Quarter 2024 Results
Page 3
August 8, 2024

 

TruBridge, Inc.

Condensed Consolidated Statements of Income

(In '000s, except per share data)

(Unaudited)

 

   

Three Months Ended June 30,

   

Six Months Ended June 30,

 
   

2024

   

2023

   

2024

   

2023

 

Revenues

                               

RCM

  $ 54,108     $ 47,760     $ 107,146     $ 96,391  

EHR

    30,622       36,862       60,831       74,464  

Total revenues

    84,730       84,622       167,977       170,855  
                                 

Expenses

                               

Costs of revenue (exclusive of amortization and depreciation)

                               

RCM

    30,269       27,119       59,866       54,302  

EHR

    13,073       17,014       25,237       34,008  

Total costs of revenue (exclusive of amortization and depreciation)

    43,342       44,133       85,103       88,310  

Product development

    8,207       8,769       18,894       17,121  

Sales and marketing

    7,815       8,132       14,408       15,089  

General and administrative

    18,878       19,057       38,274       33,510  

Amortization

    9,107       5,858       14,975       11,341  

Depreciation

    400       579       800       1,095  

Total expenses

    87,749       86,528       172,454       166,466  

Operating income (loss)

    (3,019 )     (1,906 )     (4,477 )     4,389  
                                 

Other income (expense):

                               

Other income

    91       78       1,514       346  

Interest expense

    (4,242 )     (2,664 )     (8,315 )     (5,334 )

Total other expense

    (4,151 )     (2,586 )     (6,801 )     (4,988 )
                                 

Loss before taxes

    (7,170 )     (4,492 )     (11,278 )     (599 )
                                 

Income tax benefit

    (2,121 )     (1,655 )     (3,713 )     (846 )
                                 

Net income (loss)

  $ (5,049 )   $ (2,837 )   $ (7,565 )   $ 247  
                                 

Net income (loss) per common sharebasic

  $ (0.34 )   $ (0.20 )   $ (0.51 )   $ 0.02  

Net income (loss) per common sharediluted

  $ (0.34 )   $ (0.20 )   $ (0.51 )   $ 0.02  
                                 

Weighted average shares outstanding used in per common share computations:

                               

Basic

    14,313       14,200       14,273       14,168  

Diluted

    14,313       14,200       14,273       14,168  

 

-MORE-

TruBridge Announces Second Quarter 2024 Results
Page 4
August 8, 2024

 

TruBridge, Inc.

Condensed Consolidated Balance Sheets

(In '000s, except per share data)

 

   

June 30, 2024
(Unaudited)

   

Dec. 31, 2023

 

Assets

               

Current assets

               

Cash and cash equivalents

  $ 7,709     $ 3,848  

Accounts receivable, net of allowance for expected credit losses of $3,315 and $3,631, respectively

    59,603       59,723  

Financing receivables, current portion (net of allowance for expected credit losses of $332 and $319, respectively)

    4,137       3,997  

Inventories

    793       475  

Prepaid income taxes

    2,307       1,628  

Prepaid expenses and other

    17,034       15,807  

Assets of held for sale disposal group

    -       25,977  

Total current assets

    91,583       111,455  
                 

Property & equipment, net

    8,479       8,974  

Software development costs, net

    39,741       39,139  

Operating lease assets

    3,861       5,192  

Financing receivables, net of current portion (net of allowance for expected credit losses of $56 and $97, respectively)

    607       1,226  

Other assets, net of current portion

    8,337       7,314  

Intangible assets, net

    82,960       89,213  

Goodwill

    172,573       171,909  

Deferred tax assets

    4,146       -  

Total assets

  $ 412,287     $ 434,422  
                 

Liabilities & Stockholders' Equity

               

Current liabilities

               

Accounts payable

  $ 15,854     $ 10,133  

Current portion of long-term debt

    3,074       3,141  

Deferred revenue

    9,842       8,677  

Accrued vacation

    5,458       5,410  

Liabilities of held for sale disposal group

    -       977  

Other accrued liabilities

    17,481       19,892  

Total current liabilities

    51,709       48,230  
                 

Long-term debt, net of current portion

    176,964       195,270  

Operating lease liabilities, net of current portion

    2,512       3,074  

Deferred tax liabilities

    -       1,230  

Total liabilities

    231,185       247,804  
                 

Stockholders' Equity

               

Common stock, $0.001 par value; 30,000 shares authorized; 15,561 and 15,121 shares issued, respectively

    15       15  

Treasury stock, 615 and 572 shares, respectively

    (17,434 )     (17,075 )

Accumulated other comprehensive gain

    108       -  

Additional paid-in capital

    197,846       195,546  

Retained earnings

    567       8,132  

Total stockholders' equity

    181,102       186,618  
                 

Total liabilities and stockholders' equity

  $ 412,287     $ 434,422  

 

-MORE-

 

TruBridge, Inc.

Condensed Consolidated Statements of Cash Flows

(In '000s)

(Unaudited)

 

   

Six Months Ended June 30,

 
   

2024

   

2023

 

Operating activities:

               

Net income (loss)

  $ (7,565 )   $ 247  

Adjustments to net income (loss):

               

Provision for credit losses

    358       181  

Deferred taxes

    (5,224 )     (1,533 )

Stock-based compensation

    2,300       1,124  

Depreciation

    800       1,095  

Gain on sale of business

    (1,250 )     -  

Amortization of acquisition-related intangibles

    6,253       8,029  

Amortization of software development costs

    8,722       3,312  

Amortization of deferred finance costs

    213       180  

Non-cash operating lease costs

    897       1,211  

Loss on disposal of property and equipment

    -       117  

Changes in operating assets and liabilities:

               

Accounts receivable

    654       (3,806 )

Financing receivables

    506       940  

Inventories

    (318 )     (178 )

Prepaid expenses and other

    1,502       (2,017 )

Accounts payable

    5,750       7,448  

Deferred revenue

    1,769       (1,705 )

Operating lease liabilities

    (583 )     (1,067 )

Other liabilities

    (2,375 )     (2,278 )

Prepaid income taxes

    (679 )     (1,110 )

Net cash provided by operating activities

    11,730       10,190  
                 

Investing activities:

               

Purchase of business, net of cash acquired

    (664 )     -  

Sale of business, net of cash and cash equivalents sold

    21,410       -  

Investment in software development

    (9,324 )     (12,143 )

Purchases of property and equipment

    (306 )     (72 )

Net cash provided by (used in) investing activities

    11,116       (12,215 )
                 

Financing activities:

               

Treasury stock purchases

    (358 )     (2,532 )

Payments of long-term debt principal

    (5,750 )     (1,750 )

Proceeds from revolving line of credit

    21,072       11,602  

Payments of revolving line of credit

    (33,379 )     (5,000 )

Debt issuance cots

    (529 )     -  

Net cash provided by (used in) financing activities

    (18,944 )     2,320  
                 

Increase in cash and cash equivalents

    3,902       295  
                 

Change in cash and cash equivalents included in assets sold

    (41 )        

Cash and cash equivalents, beginning of period

    3,848       6,951  

Cash and cash equivalents, end of period

  $ 7,709     $ 7,246  

 

-MORE-

 

TruBridge, Inc.

Consolidated Bookings

(In '000s)

(Unaudited) (Non-GAAP)

 

   

Three Months Ended June 30,

   

Six Months Ended June 30,

 

In '000s

 

2024

   

2023 (3)

   

2024

   

2023 (3)

 

RCM(1)

  $ 13,458     $ 13,648     $ 27,849     $ 25,748  

EHR(2)

    9,832       7,322       19,010       15,069  

Total

  $ 23,290     $ 20,970     $ 46,859     $ 40,817  

 

(1)

Generally calculated as the total contract price (for non-recurring, project-related amounts) and annualized contract value (for recurring amounts).

(2)

Generally calculated as the total contract price (for system sales) and annualized contract value (for support) for perpetual license system sales and total contract price for SaaS sales.

(3)

Adjustment was made to the 2023 bookings, due to 3rd Party Software, and Forms and Supplies being doubled accounted for in the total EHR bookings.

 

 

 

 

TruBridge, Inc.

Bookings Composition

(In '000s, except per share data)

(Unaudited) (Non-GAAP)

 

   

Three Months Ended June 30,

   

Six Months Ended June 30,

 
   

2024

   

2023 (3)

   

2024

   

2023 (3)

 

RCM

                               

Net new(1)

  $ 6,453     $ 3,395     $ 15,446     $ 9,749  

Cross-sell(1)

    7,004       10,253       12,402       15,999  

EHR

                               

Non-subscription sales(2)

    4,084       4,458       7,534       10,506  

Subscription revenue(3)

    5,749       2,864       11,477       4,563  

Total

  $ 23,290     $ 20,970     $ 46,859     $ 40,817  

 

(1)

“Net new” represents bookings from outside the Company’s core EHR client base, and “Cross-sell” represents bookings from existing EHR customers. In each case, such bookings are generally comprised of recurring revenues to be recognized ratably over a one-year period and an average timeframe for commencement of bookings-to-revenue conversion of four to six months following contract execution.

(2)

Represents nonrecurring revenues that generally exhibit a timeframe for bookings-to-revenue conversion of five to six months following contract execution.

(3)

Represents recurring revenues to be recognized on a monthly basis over a weighted-average contract period of five years, with a start date in the next 12 months and an average timeframe for commencement of bookings-to-revenue conversion of five to six months following contract execution.

 

-MORE-

 

TruBridge, Inc.

Adjusted EBITDA - by Segment

(In '000s)

(Unaudited) (Non-GAAP)

 

   

Three Months Ended June 30,

   

Six Months Ended June 30,

 

In '000s

 

2024

   

2023

   

2024

   

2023

 

RCM

  $ 7,804     $ 5,682     $ 14,202     $ 13,580  

EHR

    4,770       5,545       7,826       12,289  

Total

  $ 12,574     $ 11,227     $ 22,028     $ 25,869  

 

 

 

 

 

TruBridge, Inc.

Reconciliation of Non-GAAP Financial Measures

(In '000s)

(Unaudited)

 

   

Three Months Ended June 30,

   

Six Months Ended June 30,

 

Adjusted EBITDA:

 

2024

   

2023

   

2024

   

2023

 

Net income (loss), as reported

  $ (5,049 )   $ (2,837 )   $ (7,565 )   $ 247  

Net Income Margin

    (6.0% )     (3.4% )     (4.5% )     0.1 %

Depreciation expense

    400       597       800       1,095  

Amortization of software development costs

    5,980       1,826       8,722       3,312  

Amortization of acquisition-related intangibles

    3,126       4,014       6,253       8,029  

Stock-based compensation

    1,501       (123 )     2,300       1,124  

Severance and other non-recurring charges

    4,586       6,819       8,430       7,920  

Interest expense

    4,151       2,586       8,051       4,988  

Gain on sale of AHT

    -       -       (1,250 )     -  

Provision (benefit) for income taxes

    (2,121 )     (1,655 )     (3,713 )     (846 )

Total Adjusted EBITDA

  $ 12,574     $ 11,227     $ 22,028     $ 25,869  

Adjusted EBITDA Margin

    14.8 %     13.3 %     13.1 %     15.1 %

 

-MORE-

TruBridge Announces Second Quarter 2024 Results
Page 8
August 8, 2024

 

TruBridge, Inc.

Reconciliation of Non-GAAP Financial Measures

(In '000s, except per share data)

(Unaudited)

 

   

Three Months Ended June 30,

   

Six Months Ended June 30,

 

Non-GAAP Net Income and Non-GAAP EPS:

 

2024

   

2023

   

2024

   

2023

 

Net income (loss), as reported

  $ (5,049 )   $ (2,837 )   $ (7,565 )   $ 247  

Pre-tax adjustments for Non-GAAP EPS:

                               

Amortization of acquisition-related intangible assets

    3,126       4,014       6,253       8,029  

Stock-based compensation

    1,501       (123 )     2,300       1,124  

Severance and other nonrecurring charges

    4,586       6,819       8,430       7,920  

Non-cash interest expense

    107       90       213       180  

After-tax adjustments for Non-GAAP EPS:

                               

Tax-effect of pre-tax adjustments, at 21%

    (1,957 )     (2,269 )     (3,611 )     (3,623 )

Tax shortfall (windfall) from stock-based compensation

    4       7       113       57  

Non-GAAP net income

  $ 2,318     $ 5,701     $ 6,133     $ 13,934  

Weighted average shares outstanding, diluted

    14,313       14,200       14,273       14,168  

Non-GAAP EPS

  $ 0.16     $ 0.40     $ 0.43     $ 0.98  

 

 

 

 

 

 

TruBridge, Inc.

Electronic Health Record (EHR) Revenue Composition

(In '000s)

(Unaudited)

 

   

Three Months Ended June 30,

   

Six Months Ended June 30,

 
   

2024

   

2023

   

2024

   

2023

 

Recurring revenues - EHR

                               

Acute Care EHR

  $ 26,666     $ 30,013     $ 54,160     $ 59,353  

Post-acute Care EHR

    -       3,729       582       7,636  

Total recurring revenues - EHR

    26,666       33,742       54,742       66,989  
                                 

Non-recurring revenues - EHR

                               

Acute Care EHR

    3,956       2,775       6,008       6,750  

Post-acute Care EHR

    -       345       81       725  

Total non-recurring revenues - EHR

    3,956       3,120       6,089       7,475  
                                 

Total EHR revenues

  $ 30,622     $ 36,862     $ 60,831     $ 74,464  

 

 

-MORE-

TruBridge Announces Second Quarter 2024 Results
Page 9
August 8, 2024

 

Explanation of Non-GAAP Financial Measures

 

We report our financial results in accordance with accounting principles generally accepted in the United States of America, or “GAAP.” However, management believes that, in order to properly understand our short-term and long-term financial and operational trends, investors may wish to consider the impact of certain non-cash or non-recurring items, when used as a supplement to financial performance measures that are prepared in accordance with GAAP. These items result from facts and circumstances that vary in frequency and impact on continuing operations. Management uses these non-GAAP financial measures in order to evaluate the operating performance of the Company and compare it against past periods, make operating decisions, and serve as a basis for strategic planning. These non-GAAP financial measures provide management with additional means to understand and evaluate the operating results and trends in our ongoing business by eliminating certain non-cash expenses and other items that management believes might otherwise make comparisons of our ongoing business with prior periods more difficult, obscure trends in ongoing operations, or reduce management’s ability to make useful forecasts. In addition, management understands that some investors and financial analysts find these non-GAAP financial measures helpful in analyzing our financial and operational performance and comparing this performance to our peers and competitors.

 

As such, to supplement the GAAP information provided, we present in this press release and during the live webcast discussing our financial results the following non-GAAP financial measures: Adjusted EBITDA, Adjusted EBITDA Margin, Non-GAAP net income, and Non-GAAP earnings per share (“EPS”).

 

 

We calculate each of these non-GAAP financial measures as follows:

 

Adjusted EBITDA – Adjusted EBITDA consists of GAAP net income as reported and adjusts for (i) depreciation expense; (ii) amortization of software development costs; (iii) amortization of acquisition-related intangibles; (iv) stock-based compensation; (v) severance and other nonrecurring charges; (vi) interest expense; (vii) gain on sale of AHT; and (xiii) the provision (benefit) for income taxes.

 

Adjusted EBITDA Margin – Adjusted EBITDA Margin is calculated as Adjusted EBITDA, as defined above, divided by total revenue.

 

Non-GAAP net income – Non-GAAP net income consists of GAAP net income as reported and adjusts for (i) amortization of acquisition-related intangible assets; (ii) stock-based compensation; (iii) severance and other non-recurring charges; (iv) non-cash interest expense; (v) gain on sale of AHT; and (vi) the total tax effect of items (i) through (v).

 

Non-GAAP EPS – Non-GAAP EPS consists of Non-GAAP net income, as defined above, divided by weighted average shares outstanding (diluted) in the applicable period.

 

Certain of the items excluded or adjusted to arrive at these non-GAAP financial measures are described below:

 

Amortization of acquisition-related intangibles – Acquisition-related amortization expense is a non-cash expense arising primarily from the acquisition of intangible assets in connection with acquisitions or investments. We exclude acquisition-related amortization expense from non-GAAP financial measures because we believe (i) the amount of such expenses in any specific period may not directly correlate to the underlying performance of our business operations and (ii) such expenses can vary significantly between periods as a result of new acquisitions and full amortization of previously acquired intangible assets. Investors should note that the use of these intangible assets contributed to revenue in the periods presented and will contribute to future revenue generation, and the related amortization expense will recur in future periods.

 

-MORE-

 

 

Stock-based compensation – Stock-based compensation expense is a non-cash expense arising from the grant of stock-based awards. We exclude stock-based compensation expense from non-GAAP financial measures because we believe (i) the amount of such expenses in any specific period may not directly correlate to the underlying performance of our business operations and (ii) such expenses can vary significantly between periods as a result of the timing and valuation of grants of new stock-based awards, including grants in connection with acquisitions. Investors should note that stock-based compensation is a key incentive offered to employees whose efforts contributed to the operating results in the periods presented and are expected to contribute to operating results in future periods, and such expense will recur in future periods.

 

Severance and other nonrecurring charges – Non-recurring charges relate to certain severance and other charges incurred in connection with activities that are considered non-recurring. We exclude non-recurring expenses (primarily related to costs associated with our recent business transformation initiative and transaction-related costs) from non-GAAP financial measures because we believe (i) the amount of such expenses in any specific period may not directly correlate to the underlying performance of our business operations and (ii) such expenses can vary significantly between periods.

 

Non Cash Interest expense – Non-cash interest expense includes amortization of deferred debt issuance costs. We exclude non-cash interest expense from non-GAAP financial measures because we believe these non-cash amounts relate to specific transactions and, as such, may not directly correlate to the underlying performance of our business operations.

 

Interest expense: Interest incurred on our term loan and revolving credit facility.

 

Gain on sale of AHT: Represents the excess of proceeds received over the net assets sold from our sale of AHT, our previously wholly-owned post-acute business, in January 2024.

 

Tax shortfall (windfall) from stock-based compensation – ASU 2016-09, Improvements to Employee Share-Based Payment Accounting, became effective for the Company during the third quarter of 2017 and changes the treatment of tax shortfall and excess tax benefits arising from stock based compensation arrangements. Prior to ASU 2016-09, these amounts were recorded as an increase (for excess benefits) or decrease (for shortfalls) to additional paid-in capital. With the adoption of ASU 2016-09, these amounts are now captured in the period’s income tax expense. We exclude this component of income tax expense from non-GAAP financial measures because we believe (i) the amount of such expenses or benefits in any specific period may not directly correlate to the underlying performance of our business operations; and (ii) such expenses or benefits can vary significantly between periods as a result of the valuation of grants of new stock-based awards, the timing of vesting of awards, and periodic movements in the fair value of our common stock.

 

Management considers these non-GAAP financial measures to be important indicators of our operational strength and performance of our business and a good measure of our historical operating trends, in particular the extent to which ongoing operations impact our overall financial performance. In addition, management may use Adjusted EBITDA, Non-GAAP net income and/or Non-GAAP EPS to measure the achievement of performance objectives under the Company’s stock and cash incentive programs. Note, however, that these non-GAAP financial measures are performance measures only, and they do not provide any measure of cash flow or liquidity. Non-GAAP financial measures are not alternatives for measures of financial performance prepared in accordance with GAAP and may be different from similarly titled non-GAAP measures presented by other companies, limiting their usefulness as comparative measures. Non-GAAP financial measures have limitations in that they do not reflect all of the amounts associated with our results of operations as determined in accordance with GAAP. Additionally, there is no certainty that we will not incur expenses in the future that are similar to those excluded in the calculations of the non-GAAP financial measures presented in this press release. Investors and potential investors are encouraged to review the “Unaudited Reconciliation of Non-GAAP Financial Measures” above.

 

 

-END-

v3.24.2.u1
Document And Entity Information
Aug. 08, 2024
Document Information [Line Items]  
Entity, Registrant Name TRUBRIDGE, INC.
Document, Type 8-K
Document, Period End Date Aug. 08, 2024
Entity, Incorporation, State or Country Code DE
Entity, File Number 000-49796
Entity, Tax Identification Number 74-3032373
Entity, Address, Address Line One 54 St. Emanuel Street
Entity, Address, City or Town Mobile
Entity, Address, State or Province AL
Entity, Address, Postal Zip Code 36602
City Area Code 251
Local Phone Number 639-8100
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Entity, Emerging Growth Company false
Amendment Flag false
Entity, Central Index Key 0001169445
CommonStockParValue0001PerShare Custom [Member]  
Document Information [Line Items]  
Title of 12(b) Security Common stock, par value $0.001 per share
Trading Symbol TBRG
Security Exchange Name NASDAQ
CommonStockPurchaseRights Custom [Member]  
Document Information [Line Items]  
Title of 12(b) Security Common Stock Purchase Rights
Security Exchange Name NASDAQ

1 Year TruBridge Chart

1 Year TruBridge Chart

1 Month TruBridge Chart

1 Month TruBridge Chart

Your Recent History

Delayed Upgrade Clock